Why is India the Perfect Destination for Your Next Drug Discovery Project?

India's CRO landscape is evolving rapidly, with clinical development services taking the lead, followed by discovery chemical services. To stay ahead of shifting regulatory landscapes, CROs are enhancing their scientific writing and regulatory capabilities. Notably, biomarker development and companion diagnostics are emerging as critical areas of focus, particularly in the context of precision medicine and targeted therapies.

Therapeutic area trends reflect growing demand for CRO support in oncology, respiratory diseases, rare diseases, infectious diseases, CNS disorders, and immunology. Advances in genomics, the rise of precision medicine, and advocacy from patient groups are driving the need for specialised trials in these areas. As regulatory complexities increase and markets globalize, Indian CROs are expanding their capabilities and geographic reach to meet this demand, making them a crucial player in the future of drug discovery and development.